Specialized in Vaccine Design and Development. Custom Service Meet Your Needs. Comprehensive Vaccine Design&Manufacture Service. Learn more.
- Vaccine Service
Vaccine Development Service
Vaccine Development and Production
- Vaccine GMP Manufacturing
Process Development
GMP Manufacturing
- Vaccine Design
Target-Based Vaccine Design
Pathogen Vaccine Design
- Enzyme mRNA Products
Besides predesigned enzyme mRNA
products, custom IVT mRNA ...
- Vaccine Service
Search results
Jul 6, 2023 · So, what are vaccines made of? The quick answer? Pathogens. Vaccines familiarize your immune system — which makes antibodies to defend your body against harmful invaders — with a certain pathogen so it’ll know what to do if you become infected with that pathogen in the future.
Feb 18, 2021 · First, are all the vaccines the same? No. Different COVID-19 vaccines use different technologies, or “platforms”. The most conventional one is the inactivated vaccine. It contains dead virus.
Apr 28, 2021 · Vaccines are made up of whole bacteria or virus, or parts of them, often a protein or sugar. These active components of the vaccine, called antigens, are what trigger an immune response when in the body.
Dec 8, 2020 · Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained series. What are the ingredients in a vaccine? Vaccines contain tiny fragments of the disease-causing organism or the blueprints for making the tiny fragments.
Nov 23, 2020 · Ten years' vaccine work achieved in about 10 months. Yet no corners cut in designing, testing and manufacturing. They are two statements that sound like a contradiction, and have led some to...
Learn more about the vaccine-making process with Pfizer. Explore the meticulous journey of how vaccines are made, unraveling the science behind vaccine development.
Apr 9, 2021 · The development of several highly efficacious vaccines against a previously unknown viral pathogen, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in less than 1 year from the identification of the virus is unprecedented in the history of vaccinology.
